Skip to main content
Clinical Trials/NL-OMON29193
NL-OMON29193
Not yet recruiting
Not Applicable

A randomized clinical trial to evaluate the efficacy of polyethylene glycol versus psyllium fiber to prevent rebleeding in patients hospitalized with bleeding diverticular disease.

ot applicable0 sites260 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
ot applicable
Enrollment
260
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients between the ages of 18 and 85 years old;
  • \- Patients who are hospitalized for bleeding diverticular disease in the Elisabeth\-Tweesteden Ziekenhuis (ETZ);
  • \- Patients with diverticular disease based on colonoscopy \<5 years.

Exclusion Criteria

  • \- Other bleeding diseases of the colon requiring medicinal treatment such as IBD or infection;
  • \- Patients hypersensitive to macrogol or psyllium;
  • \- Surgical treatment following initial episode of bleeding diverticular disease;
  • \- Patients using polyethylene glycol or psyllium fiber regularly, more than twice daily;
  • \- Patients who are pregnant, lactating or planning pregnancy while enrolled in the study;
  • \- Patients who are unsuitable for inclusion in the study in the opinion of the investigator for any reason that may compromise the subject's safety or confound data interpretation.

Outcomes

Primary Outcomes

Not specified

Similar Trials